Sale!

WDR11 Gene Hypogonadotropic Hypogonadism Type 14 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The WDR11 Gene Hypogonadotropic Hypogonadism Type 14 NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the WDR11 gene, which are responsible for causing hypogonadotropic hypogonadism type 14. This specialized test utilizes next-generation sequencing (NGS) technology to provide comprehensive analysis of the WDR11 gene, helping diagnose individuals with delayed puberty, infertility, and reproductive hormone deficiencies. The test is particularly valuable for patients experiencing symptoms of hypogonadism, including absent or delayed puberty, infertility, low libido, and menstrual irregularities. By identifying the specific genetic cause, healthcare providers can develop targeted treatment strategies and provide accurate genetic counseling. The test costs $500 USD and provides results within 3-4 weeks, offering crucial insights for reproductive health management and family planning decisions.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

WDR11 Gene Hypogonadotropic Hypogonadism Type 14 NGS Genetic DNA Test

Understanding WDR11 Gene Hypogonadotropic Hypogonadism Type 14

WDR11 Gene Hypogonadotropic Hypogonadism Type 14 is a rare genetic disorder affecting the reproductive system, characterized by impaired production or secretion of gonadotropin-releasing hormone (GnRH). This condition disrupts the normal function of the hypothalamic-pituitary-gonadal axis, leading to insufficient production of sex hormones and subsequent reproductive challenges.

What This Test Measures and Detects

Our advanced NGS Genetic DNA Test specifically analyzes the WDR11 gene for mutations associated with hypogonadotropic hypogonadism type 14. The test detects:

  • Point mutations in the WDR11 gene coding regions
  • Insertions and deletions affecting gene function
  • Copy number variations impacting WDR11 expression
  • Pathogenic variants disrupting normal protein function
  • Genetic markers associated with impaired GnRH neuron development

Who Should Consider This Genetic Test

This comprehensive genetic analysis is recommended for individuals presenting with:

  • Delayed or absent puberty beyond age 14 in females and age 15 in males
  • Primary amenorrhea (absence of menstrual periods)
  • Infertility with unexplained causes
  • Low levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
  • Family history of hypogonadotropic hypogonadism
  • Anosmia or hyposmia (reduced sense of smell)
  • Underdeveloped secondary sexual characteristics
  • Unexplained reproductive hormone deficiencies

Clinical Benefits of Genetic Testing

Undergoing the WDR11 Gene Hypogonadotropic Hypogonadism Type 14 NGS Genetic DNA Test provides numerous clinical advantages:

  • Accurate Diagnosis: Confirms the genetic basis of reproductive symptoms
  • Personalized Treatment: Enables targeted hormone replacement therapy
  • Family Planning Guidance: Provides crucial information for reproductive decisions
  • Genetic Counseling: Supports informed family planning and risk assessment
  • Early Intervention: Facilitates timely management of reproductive health
  • Differential Diagnosis: Helps distinguish from other forms of hypogonadism

Understanding Your Test Results

Our comprehensive genetic analysis provides clear, actionable results:

Positive Result Interpretation

A positive result indicates the presence of pathogenic mutations in the WDR11 gene. This confirms the diagnosis of hypogonadotropic hypogonadism type 14 and enables:

  • Initiation of appropriate hormone replacement therapy
  • Referral to reproductive endocrinology specialists
  • Family genetic counseling sessions
  • Development of long-term reproductive health management plans

Negative Result Interpretation

A negative result suggests no pathogenic WDR11 gene mutations were detected. This outcome helps:

  • Rule out WDR11-related hypogonadotropic hypogonadism
  • Guide further diagnostic evaluation for other causes
  • Focus investigation on alternative genetic or acquired conditions
  • Provide reassurance for family planning decisions

Test Information and Pricing

Test Component Details
Test Name WDR11 Gene Hypogonadotropic Hypogonadism Type 14 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialty Gynecology and Reproductive Genetics

Pre-Test Requirements

Before scheduling your test, please ensure:

  • Complete clinical history documentation
  • Genetic counseling session to create family pedigree chart
  • Discussion of test implications with healthcare provider
  • Understanding of potential outcomes and next steps

Nationwide Testing Availability

We provide comprehensive genetic testing services across the United States, with convenient locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.

Take Control of Your Reproductive Health Today

Don’t let unexplained reproductive symptoms affect your quality of life. Our WDR11 Gene Hypogonadotropic Hypogonadism Type 14 NGS Genetic DNA Test provides the answers you need for informed healthcare decisions. With our discounted price of $500 USD and comprehensive genetic analysis, you can gain valuable insights into your reproductive health and take proactive steps toward effective management.

Ready to schedule your genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Our team is available to answer your questions and guide you through the testing process with compassion and expertise.